Evaluating—and understanding—breast cancer studies at SABCS
T-DM1 tradeoffs: not worth the costs and side effects in early stage breast cancer
Good News and Unicorns on Day 1 of SABCS
Tell the FDA to Require Stronger Breast Implant Labeling
Thank You for Saying Never to Forever Chemicals
Voices from 3M’s Backyard
3M’s Toxic Legacy
4 Reasons I’m Telling 3M No More PFAS!
Beyond the PinkNews Categories
- Articles (410)
- BCA Action Alerts (308)
- BCA Events (126)
- BCA News (630)
- E-Alerts (354)
- Podcasts (5)
- Press Releases (44)
-
News Feed
- Dec 13 2019 Evaluating—and understanding—breast cancer studies at SABCS By Karuna Jaggar, Executive Director For 42 years, breast cancer researchers and... ... read more
- Dec 12 2019 T-DM1 tradeoffs: not worth the costs and side effects in early stage breast cancer Just because there is an FDA approved treatment, should it be offered to everyone? Dr Tolaney from the Dana Farber Cancer Institute presented data (GS1-05)... ... read more
- Dec 12 2019 Good News and Unicorns on Day 1 of SABCS by Karuna Jaggar, Executive Director I feel like I saw unicorn today. I began Day 1 of the San Antonio Breast Cancer Symposium with this tweet: “Back for my 8th tour of breast cancer research at #SABCS19. Here’s... ... read more
a project of Breast Cancer Action